These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 38760717)
21. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer. Basu A; Upadhyay P; Ghosh A; Bose A; Gupta P; Chattopadhyay S; Chattopadhyay D; Adhikary A Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129841. PubMed ID: 33412224 [TBL] [Abstract][Full Text] [Related]
22. Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression. Huang TT; Tseng LM; Chen JL; Chu PY; Lee CH; Huang CT; Wang WL; Lau KY; Tseng MF; Chang YY; Chiang TY; Ueng YF; Lee HC; Dai MS; Liu CY EBioMedicine; 2020 Apr; 54():102717. PubMed ID: 32268268 [TBL] [Abstract][Full Text] [Related]
23. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis. Jin J; Liu H; Jin M; Li W; Xu H; Wei F Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866 [TBL] [Abstract][Full Text] [Related]
24. [Effect and mechanism of Compound Shougong Powder in attenuating triple-negative breast cancer progression by reversing epithelial-to-mesenchymal transition]. Jiao ZY; Zhu YF; Chen ST; Pan YX; Song H; Chen FY Zhongguo Zhong Yao Za Zhi; 2024 Jul; 49(14):3868-3877. PubMed ID: 39099360 [TBL] [Abstract][Full Text] [Related]
25. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1. Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328 [No Abstract] [Full Text] [Related]
26. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling. Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785 [TBL] [Abstract][Full Text] [Related]
27. Radiation exposure triggers the progression of triple negative breast cancer via stabilizing ZEB1. Lin Y; Bai X; Zhou W; He Y; Wu Y; Wang X Biomed Pharmacother; 2018 Nov; 107():1624-1630. PubMed ID: 30257380 [TBL] [Abstract][Full Text] [Related]
28. Hsa-miR-497-3p impedes the proliferation and invasion of triple-negative breast cancer cells by controlling epithelial-mesenchymal transition through ZEB1 targeting. Dong Q; Chen H; Li Y; Kong Y; Geng C; Liu Y Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):78-83. PubMed ID: 37715420 [TBL] [Abstract][Full Text] [Related]
29. LINC01614 activated by SP1 promoted malignant behavior of triple-negative breast cancer cells via the WNT/b-Catenin signaling pathway. Chen T; Shi K; Sun S Rev Invest Clin; 2024 Oct; 76(4):185-194. PubMed ID: 39419019 [TBL] [Abstract][Full Text] [Related]
30. VGLL4 interacts with STAT3 to function as a tumor suppressor in triple-negative breast cancer. Song H; Luo Q; Deng X; Ji C; Li D; Munankarmy A; Jian W; Zhao J; Fang L Exp Mol Med; 2019 Nov; 51(11):1-13. PubMed ID: 31748508 [TBL] [Abstract][Full Text] [Related]
31. STAT3-induced NCK1 elevation promotes migration of triple-negative breast cancer cells via regulating ERK1/2 signaling. He P; Sheng J; Qi J; Bai X; Li J; Wang F; Yuan Y; Zheng X Mol Biol Rep; 2022 Jan; 49(1):267-278. PubMed ID: 34846647 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer. Granados-Principal S; Liu Y; Guevara ML; Blanco E; Choi DS; Qian W; Patel T; Rodriguez AA; Cusimano J; Weiss HL; Zhao H; Landis MD; Dave B; Gross SS; Chang JC Breast Cancer Res; 2015 Feb; 17(1):25. PubMed ID: 25849745 [TBL] [Abstract][Full Text] [Related]
33. Myeloid Zinc Finger 1 (MZF1) Maintains the Mesenchymal Phenotype by Down-regulating IGF1R/p38 MAPK/ERα Signaling Pathway in High-level MZF1-expressing TNBC cells. Yue CH; Liu JY; Chi CS; Hu CW; Tan KT; Huang FM; Pan YR; Lin KI; Lee CJ Anticancer Res; 2019 Aug; 39(8):4149-4164. PubMed ID: 31366500 [TBL] [Abstract][Full Text] [Related]
34. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877 [TBL] [Abstract][Full Text] [Related]
35. The inhibition of miR-126 in cell migration and invasion of cervical cancer through regulating ZEB1. Xu J; Wang H; Wang H; Chen Q; Zhang L; Song C; Zhou Q; Hong Y Hereditas; 2019; 156():11. PubMed ID: 31007650 [TBL] [Abstract][Full Text] [Related]
36. Obesity-associated metabolic inflammation promotes triple-negative breast cancer progression through the interleukin-6/STAT3/pentraxin 3/matrix metalloproteinase 7 axis. Xie H; Ruan G; Wei L; Zhang H; Shi J; Lin S; Liu C; Liu X; Zheng X; Chen Y; Deng L; Shi H Int Immunopharmacol; 2024 Jul; 136():112332. PubMed ID: 38805776 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator. Chen H; Li Z; Zhang L; Zhang L; Zhang Y; Wang Y; Xu M; Zhong Q Ann Clin Lab Sci; 2020 Jul; 50(4):519-527. PubMed ID: 32826250 [TBL] [Abstract][Full Text] [Related]
38. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD. Wu D; Jia H; Zhang Z; Li S Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253 [TBL] [Abstract][Full Text] [Related]
39. ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1. Song W; Tang L; Xu Y; Sun Q; Yang F; Guan X J Exp Clin Cancer Res; 2017 Jun; 36(1):75. PubMed ID: 28583190 [TBL] [Abstract][Full Text] [Related]
40. Silencing TRAIP suppresses cell proliferation and migration/invasion of triple negative breast cancer via RB-E2F signaling and EMT. Zheng Y; Jia H; Wang P; Liu L; Chen Z; Xing X; Wang J; Tan X; Wang C Cancer Gene Ther; 2023 Jan; 30(1):74-84. PubMed ID: 36064576 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]